CTI BioPharma Corp (CTIC)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
James A. Bianco
Employees:
46
3101 WESTERN AVENUE, SUITE 800, SEATTLE, WA 98121
2062827100

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally.

Data derived from most recent annual or quarterly report
Market Cap 214.657 Million Shares Outstanding96.692 Million Avg 30-day Volume 1.359 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.15
Price to Revenue0.0 Debt to Equity0.1113 EBITDA-51.091 Million
Price to Book Value6.1689 Operating Margin0.0 Enterprise Value198.937 Million
Current Ratio3.189 EPS Growth-0.072 Quick Ratio3.079
1 Yr BETA 0.8112 52-week High/Low 4.13 / 1.43 Profit Margin0.0
Operating Cash Flow Growth-51.6965 Altman Z-Score-49.9822 Free Cash Flow to Firm -31.94 Million
View SEC Filings from CTIC instead.

View recent insider trading info

Funds Holding CTIC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTIC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

3.5 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JONES DAVID ANDREW EXECUTIVE VICE PRESIDENT

  • Officer
18,553 2021-12-31 1

PARKS DIANE L.

  • Director
0 2021-08-24 1

CRAIG ADAM R PRESIDENT AND CEO

  • Officer
  • Director
13,500 2021-06-30 1

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • Director
  • 10% Owner
  • SEE REMARKSSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
2,153,239 2021-04-01 2

FISCHER LAURENT

  • Director
80,000 2021-03-10 1

PARKINSON DAVID ROSS

  • Director
80,000 2021-03-10 1

PERRY MATTHEW D

  • Director
80,000 2021-03-10 1

METZGER MICHAEL A

  • Director
80,000 2021-03-10 1

TUCKSON REED VAUGHN

  • Director
80,000 2021-03-10 1

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • 10% Owner
7,520,600 2021-01-07 0

KIRSKE DAVID EVP, CHIEF FINANCIAL OFFICER

  • Officer
203,798 2020-07-01 0

SEELEY BRUCE J. EVP, CHIEF OPERATING OFFICER

  • Officer
237,500 2020-07-01 0

BVF GP HOLDINGS LLC

BVF I GP LLC

BVF II GP LLC

  • 10% Owner
  • SEE EXPLANATION OF RESPONSES
5,150,400 2020-03-02 0

TELLING FRED

  • Director
0 2018-09-18 0

SINGER JACK W EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-05-16 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
1,782,594 2018-02-08 2

LOVE RICHARD L

  • Director
73,718 2017-09-28 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ISALY SAMUEL D

  • 10% Owner
5,000,000 2017-06-13 0

NUDELMAN PHILLIP M PHD

  • Director
73,129 2017-04-29 0

PLUNKETT MATTHEW EVP, CHIEF BUSINESS OFFICER

  • Officer
  • Director
0 2017-03-01 0

BIANCO JAMES A

  • Director
0 2016-10-02 0

MUNDINGER MARY ONEIL

  • Director
360,019 2016-04-29 0

BIANCO LOUIS A EVP, FINANCE & ADMINISTRATION

  • Officer
622,970 2016-03-21 0

BAUER JOHN H

  • Director
0 2015-09-23 0

IGNAGNI KAREN

  • Director
0 2015-09-23 0

BAXTER HEALTHCARE SA

  • 10% Owner
No longer subject to file 2015-04-30 0

GREGORIAN VARTAN

  • Director
468,937 2014-03-28 0

BAXTER HEALTHCARE SA

BAXTER INTERNATIONAL INC

  • 10% Owner
15,673,981 2013-11-25 0

BENNER STEVEN E EVP, CHIEF MEDICAL OFFICER

  • Officer
396,705 2013-03-21 0

PHILIPS CRAIG

  • FORMER PRESIDENT
414 2012-11-19 0

ERAMIAN DANIEL G EVP, CORPORATE COMMUNICATIONS

  • Officer
354,350 2012-09-20 0

STROMATT SCOTT EVP,CLINICAL DEV & REG AFFAIR

  • Officer
No longer subject to file 2008-04-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

JONES DAVID ANDREW - Officer EXECUTIVE VICE PRESIDENT by 401(k)

2022-01-07 15:55:32 -0500 2021-12-31 J 163 a 2,784 indirect 5.5556 5.5556 2 0.0 1

JONES DAVID ANDREW - Officer EXECUTIVE VICE PRESIDENT by esop

2022-01-07 15:55:32 -0500 2021-12-31 J 544 a 9,814 indirect 5.5556 5.5556 2 0.0 1

CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

2021-12-02 17:16:07 -0500 2021-12-02 P 1,322 $1.52 a 11,322 direct 3.7267 17.3913 17.3913 6 0.0 1

CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

2021-12-02 17:16:07 -0500 2021-12-02 P 2,178 $1.53 a 13,500 direct 3.7267 17.3913 17.3913 6 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CTI BIOPHARMA CORP CTIC 2022-01-17 22:15:04 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 21:45:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 21:15:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 20:45:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 20:15:04 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 19:45:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 19:15:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 18:45:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 18:15:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 17:45:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 17:15:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 16:45:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 16:15:04 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 15:45:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 15:15:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 14:45:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 14:15:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 13:45:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 13:15:03 UTC -1.0947 1.1647 1800000
CTI BIOPHARMA CORP CTIC 2022-01-17 12:45:03 UTC -1.0947 1.1647 1800000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.62% 2015-04-23 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.59% 2015-04-30 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-05-06 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.58% 2015-05-07 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-05-28 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.59% 2015-05-29 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.47% 2015-06-03 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.5% 2015-06-15 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-07-27 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.59% 2015-07-31 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-08-06 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.58% 2015-08-07 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.62% 2015-10-27 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.51% 2015-10-30 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.23% 2015-11-06 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.19% 2015-11-26 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.09% 2015-12-23 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.88% 2015-12-29 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.91% 2016-01-12 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.02% 2016-02-11 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.99% 2016-02-25 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.0% 2016-03-18 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.1% 2016-03-30 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.22% 2016-05-03 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.19% 2016-05-11 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.09% 2016-06-06 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.96% 2016-07-26 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.89% 2016-08-16 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.91% 2016-08-29 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.89% 2016-09-09 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.78% 2016-12-05 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.82% 2017-01-05 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.91% 2017-01-09 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.0% 2017-01-11 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.1% 2017-01-23 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.08% 2017-01-24 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.1% 2017-01-27 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.09% 2017-02-14 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.73% 2017-06-06 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.48% 2017-06-14 Italy
Jane Street Group, LLC CTI BIOPHARMA CORP 0.56% 2013-12-20 Italy
Jane Street Group, LLC CTI BIOPHARMA CORP 0.41% 2014-01-02 Italy
Jane Street Group, LLC CTI BIOPHARMA CORP 0.74% 2014-01-13 Italy
Jane Street Group, LLC CTI BIOPHARMA CORP 0.35% 2014-01-14 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.0% 2013-01-10 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.94% 2013-01-22 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.01% 2013-01-25 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.99% 2013-01-30 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.01% 2013-02-01 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.99% 2013-02-08 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.0% 2013-02-12 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.23% 2013-02-15 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.18% 2013-02-20 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.25% 2013-02-22 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.17% 2013-02-26 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.07% 2013-03-01 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.98% 2013-03-22 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.04% 2013-03-27 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.96% 2013-03-28 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.85% 2013-04-10 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.28% 2013-04-11 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.14% 2013-04-12 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.73% 2013-04-15 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.8% 2013-04-16 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.73% 2013-04-17 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.68% 2013-04-19 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.53% 2013-04-22 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.49% 2013-04-25 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.59% 2013-06-28 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.35% 2013-07-01 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.57% 2013-10-02 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.6% 2013-10-03 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.85% 2013-10-04 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.71% 2013-10-09 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.67% 2013-10-14 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.7% 2013-10-15 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.66% 2013-10-17 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.55% 2013-10-22 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.61% 2013-10-24 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.55% 2013-10-25 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.44% 2013-10-28 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.07% 2012-11-30 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.97% 2012-12-03 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.35% 2012-12-04 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.42% 2012-12-05 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.37% 2012-12-06 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.54% 2012-12-07 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.37% 2012-12-10 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.15% 2012-12-12 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.05% 2012-12-18 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.95% 2012-12-19 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.19% 2012-12-21 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.24% 2012-12-24 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.3% 2012-12-26 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.29% 2012-12-28 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.38% 2013-01-04 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.0% 2013-01-09 Italy
Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.5% 2015-06-29 Italy
Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.48% 2015-08-17 Italy
Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.52% 2017-02-07 Italy
Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.47% 2017-03-13 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-04-03 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2013-04-17 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2013-05-10 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-05-31 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-07-09 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-08-19 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2013-09-16 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-09-17 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-09-18 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-09-20 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-09-23 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.46% 2013-09-26 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.62% 2014-02-28 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.71% 2014-03-04 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.57% 2014-03-07 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.44% 2014-03-10 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2014-04-30 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.63% 2014-05-01 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.74% 2014-05-02 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.8% 2014-05-06 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.79% 2014-05-09 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-05-27 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.71% 2014-05-28 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-05-30 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-06-03 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.67% 2014-06-17 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-07-24 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-08-26 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-09-18 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-10-14 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-10-28 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.67% 2014-11-07 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-11-12 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.61% 2014-11-19 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-11-20 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2014-11-21 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-11-24 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.61% 2014-12-04 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-12-05 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2014-12-09 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-12-26 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.47% 2014-12-31 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2015-02-02 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2015-02-24 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.58% 2015-02-25 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.61% 2015-03-05 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.78% 2015-03-09 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.66% 2015-03-13 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.74% 2015-03-16 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.83% 2015-03-17 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.75% 2015-03-26 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2015-03-30 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.55% 2015-04-07 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2015-04-08 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2015-06-19 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2015-06-26 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2015-07-10 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.67% 2015-07-13 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2015-08-27 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2015-10-28 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2017-02-03 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2017-05-22 Italy

Elevate your investments